Honorary Professor Steve Duffull
Honorary Professor
School of Pharmacy and Pharmaceutical Sciences
Book Chapters
Kimko, H. and Duffull, S. B. (2003). Introduction to Simulation for Design of Clinical Trials. Simulation for Designing Clinical Trials: A Pharmacokinetic-Pharmacodynamic Modeling Perspective. (pp. 1-16) edited by H.C. Kimko and S.B. Duffull. New York: Marcel Dekker.
Monteleone, J. and Duffull, S. B. (2003). Choice of Best Design. Simulation for Designing Clinical Trials: A Pharmacokinetic-Pharmacodynamic Modeling Perspective. (pp. 173-200) edited by H.C. Kimko and S.B. Duffull. New York: Marcel Dekker.
Nestorov, I., Graham, G. G., Aarons, L. and Duffull, S. B. (2003). Model-based Integration for Clinical Trial Simulation and Design: A Phase ll Case Study for Naratriptan. Simulation for Designing Clinical Trials: A Pharmacokinetic-Pharmacodynamic Modeling Perspective. (pp. 313-325) edited by H.C. Kimko and S.B. Duffull. New York: Marcel Dekker.
Journal Articles
Barras, Michael A., Duffull, Stephen B., Atherton, John J. and Green, Bruce (2010). Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations. Therapeutic Drug Monitoring, 32 (4), 482-488. doi: 10.1097/FTD.0b013e3181e64846
Zin, Che S., Nissen, Lisa M., O'Callaghan, James P., Duffull, Stephen B., Smith, Maree T. and Moore, Brendan J. (2010). A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. Journal of Pain, 11 (5), 462-471. doi: 10.1016/j.jpain.2009.09.003
O'Shea, Stacey, Duffull, Stephen and Johnson, David W. (2009). Aminoglycosides in hemodialysis patients: Is the current practice of post dialysis dosing appropriate. Seminars in Dialysis, 22 (3), 225-230. doi: 10.1111/j.1525-139X.2008.00554.x
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2009). Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events. British Journal of Clinical Pharmacology, 68 (5), 700-711. doi: 10.1111/j.1365-2125.2009.03518.x
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). Individualized compared with conventional dosing of enoxaparin. Clinical Pharmacology & Therapeutics, 83 (6), 882-888. doi: 10.1038/sj.clpt.6100399
Chan, A. S. Y., Isbister, G. K., Kirkpatrick, C. M. J. and Duffull, S. B. (2008). Assessing risk of a prolonged QT interval-a survey of emergency physicians. International Journal of Emergency Medicine, 1 (1), 35-41. doi: 10.1007/s12245-008-0014-6
Janmahasatian, S., Duffull, S. B., Chagnac, A., Kirkpatrick, C. M.J. and Green, B. (2008). Lean body mass normalizes the effect of obesity on renal function. British Journal of Clinical Pharmacology, 65 (6), 964-965. doi: 10.1111/j.1365-2125.2008.03112.x
Roos, J. F., Kirkpatrick, C. M. J., Tett, S. E., MaLachlan, A. J. and Duffull, S. B. (2008). Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infection. British Journal of Clinical Pharmacology, 66 (4), 455-466. doi: 10.1111/j.1365-2125.2008.03247.x
Tanos, P. P., Isbister, G. K., Lalloo, D. G., Kirkpatrick, C. M. J. and Duffull, S. B. (2008). A model for venom-induced consumptive coagulopathy in snake bite. Toxicon, 52 (7), 769-780. doi: 10.1016/j.toxicon.2008.08.013
Han, P. Y., Duffull, S. B., Kirkpatrick, C. M. J. and Green, B. (2007). Dosing in obesity: A simple solution to a big problem. Clinical Pharmacology & Therapeutics, 82 (5), 505-508. doi: 10.1038/sj.clpt.2007.6100381
Hennig, Stefanie, Waterhouse, Timothy H., Bell, Scott C., France, Megan, Wainwright, Claire E., Miller, Hugh, Charles, Bruce G. and Duffull, Stephen B. (2007). A D-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients. British Journal of Clinical Pharmacology, 63 (4), 438-450. doi: 10.1111/j.1365-2125.2006.02778.x
Isbister, Geoffrey K., Friberg, Lena E. and Duffull, Stephen B. (2007). Application of pharmacokinetic-pharmacodynamic modeling in management of QT abnormalities after citalopram overdose. Reply to A. Manini. Intensive Care Medicine, 33 (4), 739-739. doi: 10.1007/s00134-006-0506-x
Mould, D. R., Denman, N. G. and Duffull, S. (2007). Using disease progression models as a tool to detect drug effect. Clinical Pharmacology and Therapeutics, 82 (1), 81-86. doi: 10.1038/sj.clpt.6100228
Chan, A., Isbister, G. K., Kirkpatrick, C. M. J. and Duffull, S. B. (2007). Drug-induced QT prolongation and torsades de pointes: Evaluation of a QT nomogram. QJM: An International Journal of Medicine, 100 (10), 609-615. doi: 10.1093/qjmed/hcm072
Isbister, G. K., Friberg, L. E., Stokes, B., Buckley, N. A., Lee, C., Gunja, N., Brown, S. G., MacDonald, E., Graudins, A., Hoidgate, A. and Duffull, S. B. (2007). Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Annals of Emergency Medicine, 50 (5), 593-600. doi: 10.1016/j.annemergmed.2007.03.009
McGree, J. M., Duffull, S. B., Eccleston, J. A. and Ward, L. C. (2007). Optimal designs for studying bioimpedance. Physiological Measurement, 28 (12), 1465-1483. doi: 10.1088/0967-3334/28/12/002
Isbister, Geoffrey K., Friberg, Lena E. and Duffull, Stephen B. (2007). Reply to Dr. Megarbane et al. regarding "Pharmacokinetic/pharmacodynamic modelling of cardiac toxicity in venlafaxine overdose". Intensive Care Medicine, 33 (1), 197-197. doi: 10.1007/s00134-006-0418-9
Teigen, Mette Maja B., Duffull, Stephen, Dang, Lily and Johnson, David W. (2006). Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis. Journal of Clinical Pharmacology, 46 (11), 1259-1267. doi: 10.1177/0091270006292987
Friberg, L. E., Isbister, G. K. and Duffull, S. B. (2006). Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. British Journal of Clinical Pharmacology, 61 (2), 177-190. doi: 10.1111/j.1365-2125.2005.02546.x
Dansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S. E. (2006). Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients. Journal of Clinical Pharmacy And Therapeutics, 31 (1), 17-25. doi: 10.1111/j.1365-2710.2006.00697.x
Waterhouse, T. H., Eccleston, J. A. and Duffull, S. B. (2006). Optimal crossover designs for logistic regression models in pharmacodynamics. Journal of Biopharmaceutical Statistics, 16 (6), 881-894. doi: 10.1080/10543400600851880
Dansirikul, Chantaratsamon, Morris, Raymond G., Tett, Susan E. and Duffull, Stephen B. (2006). A Bayesian approach for population pharmacokinetic modelling of sirolimus. British Journal of Clinical Pharmacology, 62 (4), 420-434. doi: 10.1111/j.1365-2125.2005.02533.x
Dang, Lily and Duffull, Stephen (2006). Development of a semimechanistic model to describe the pharmacokinetics of gentamicin in patients receiving Hemodialysis. Journal of Clinical Pharmacology, 46 (6), 662-673. doi: 10.1177/0091270006286902
Feng, Y, Green, B, Duffull, SB, Kane-Gill, SL, Bobek, MB and Bies, RR (2006). Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation. British Journal of Clinical Pharmacology, 62 (2), 165-176. doi: 10.1111/j.1365-2125.2006.02650.x
Staatz, Christine E., Duffull, Stephen B., Kiberd, Bryce, Fraser, Albert D. and Tett, Susan E. (2005). Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation. European Journal of Clinical Pharmacology, 61 (7), 507-516. doi: 10.1007/s00228-005-0927-4
Dansirikul, Chantaratsamon, Choi, Malcolm and Duffull, Stephen B. (2005). Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel((R)). Computers in Biology and Medicine, 35 (5), 389-403. doi: 10.1016/j.compbiomed.2004.02.008
Waterhouse, T. H., Redmann, S., Duffull, S. B. and Eccleston, J. A. (2005). Optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics in cystic fibrosis patients. Journal of Pharmacokinetics And Pharmacodynamics, 32 (3-4), 521-545. doi: 10.1007/s10928-005-0026-2
Duffull, Stephen, Waterhouse, Tim and Eccleston, John (2005). Some considerations on the design of population pharmacokinetic studies. Journal of Pharmacokinetics and Pharmacodynamics, 32 (3-4), 441-457. doi: 10.1007/s10928-005-0034-2
Duffull, SB, Kirkpatrick, CMJ, Green, B and Holford, NHG (2005). Analysis of population pharmacokinetic data using NONMEM and WinBUGS. Journal of Biopharmaceutical Statistics, 15 (1), 53-73. doi: 10.1081/BIP-200040824
Janmahasatian, S, Duffull, SB, Ash, S, Ward, LC, Byrne, NM and Green, B (2005). Quantification of lean bodyweight. Clinical Pharmacokinetics, 44 (10), 1051-1065. doi: 10.2165/00003088-200544100-00004
Friberg, Lena E.., Isbister, Geoffrey K., Hackett, L. Peter and Duffull, Stephen B. (2005). The population pharmacokinetics of citalopram after deliberate self-poisoning: A Bayesian approach. Journal of Pharmacokinetics and Pharmacodynamics, 32 (3-4), 571-605. doi: 10.1007/s10928-005-0022-6
Dansirikul, C., Duffull, S. B., Morris, R. G. and Tett, S. E. (2005). Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients. British Journal of Clinical Pharmacology, 60 (5), 560-565. doi: 10.1111/j.1365-2125.2005.02473.x
Green, B. and Duffull, S. B. (2004). What is the best size descriptor to use for pharmacokinetic studies in the obese?. British Journal of Clinical Pharmacology, 58 (2), 119-133. doi: 10.1111/j.1365-2125.2004.02157.x
Atcheson, Bronwyn A., Taylor, Paul J., Kirkpatrick, Carl M. J., Duffull, Stephen B., Mudge, David W., Pillans, Peter I., Johnson, David W. and Tett, Susan E. (2004). Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Therapeutic Drug Monitoring, 26 (3), 284-286. doi: 10.1097/00007691-200406000-00011
Duffull, SB, Dooley, MJ, Green, B, Poole, SG and Kirkpatrick, CMJ (2004). A standard weight descriptor for dose adjustment in the obese patient. Clinical Pharmacokinetics, 43 (15), 1167-1178. doi: 10.2165/00003088-200443150-00007
Dansirikul, C, Staatz, CE, Duffull, SB, Taylor, PJ, Lynch, SV and Tett, SE (2004). Sampling times for monitoring tacrolimus in stable adult liver transplant recipients. Therapeutic Drug Monitoring, 26 (6), 593-599. doi: 10.1097/00007691-200412000-00003
Green, Bruce and Duffull, Stephen B. (2003). Development of a dosing strategy for enoxaparin in obese patients. British Journal of Clinical Pharmacology, 56 (1), 96-103. doi: 10.1046/j.1365-2125.2003.01849.x
Green, B and Duffull, SB (2003). Prospective evaluation of a D-optimal designed population pharmacokinetic study. Journal of Pharmacokinetics And Pharmacodynamics, 30 (2), 145-161. doi: 10.1023/A:1024467714170
Shum, B, Duffull, SB, Taylor, PJ and Tett, SE (2003). Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil. British Journal of Clinical Pharmacology, 56 (2003), 188-197. doi: 10.1046/j.1365-2125.2003.01863.x
Kirkpatrick, CMJ, Duffull, SB, Begg, EJ and Frampton, C (2003). The use of a change in gentamicin clearance as an early predictor of gentamicin-induced nephrotoxicity. Therapeutic Drug Monitoring, 25 (5), 623-630. doi: 10.1097/00007691-200310000-00012
Begg, Evan J., Duffull, Stephen B., Hackett, L. Peter and Ilett, Kenneth F. (2002). Studying Drugs in Human Milk: Time to Unify the Approach. Journal of Human Lactation, 18 (4), 323-332. doi: 10.1177/089033402237904
Green, B, Duffull, S, Cottrell, N and D'Emden, M (2002). Myocardial infarction and type II diabetes - preferential treatment for high risk patients?. Journal of Clinical Pharmacy And Therapeutics, 27 (5), 371-376. doi: 10.1046/j.1365-2710.2002.00436.x
Evans, N. D., Godfrey, K. R., Chapman, M. J., Chappell, M. J., Aarons, L. and Duffull, S. B. (2001). An identifiability analysis of a parent-metabolite pharmacokinetic model for ivabradine.. Journal of Pharmacokinetics & Pharmacodynamics, 28 (1), 93-105. doi: 10.1023/A:1011521819898
Duffull, SB (2001). Design of clinical pharmacology trials. Clinical And Experimental Pharmacology And Physiology, 28 (11), 905-912. doi: 10.1046/j.1440-1681.2001.03546.x
Retout, S., Duffull, S. B. and Mentre, F. (2001). Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs.. Computer Methods & Programs in Biomedicine, 65 (2), 141-151. doi: 10.1016/S0169-2607(00)00117-6
Stickland, M. D., Kirkpatrick, C., Begg, E., Duffull, S. B., Oddie, S. J. and Darlow, B. (2001). An extended interval dosing method for gentamicin in neonates. Journal of Antimicrobial Chemotherapy, 48 (6), 887-893. doi: 10.1093/jac/48.6.887
Charles, BG and Duffull, SB (2001). Pharmacokinetic software for the health sciences - Choosing the right package for teaching purposes. Clinical Pharmacokinetics, 40 (6), 395-403. doi: 10.2165/00003088-200140060-00001
Duffull, S. B. and Tett, S. E. (2001). Concepts for critical appraisal of an original research paper.. Australian Journal of Hospital Pharmacy, 31 (3), 200-205.
Duffull, S. B., Mentre, F. and Aarons, L. (2001). Optimal design of a population pharmacodynamic experiment for ivabradine.. Pharmaceutical Research, 18 (1), 83-89. doi: 10.1023/A:1011035028755
Duffull, Stephen B. and Aarons, Leon (2000). Development of a sequential linked pharmacokinetic and pharmacodynamic simulation model for evabradine in healthy volunteers. European Journal of Pharmaceutical Sciences, 10 (4), 275-284. doi: 10.1016/S0928-0987(00)00085-3
Yee, J. Y. V. and Duffull, S. B. (2000). The effect of body weight on dalteparin pharmacokinetics: A preliminary study. European Journal of Clinical Pharmacology, 56 (56), 293-297. doi: 10.1007/s002280000141
Duffull, S. B., Chabaud, S., Nony, P., Laveille, C., Girard, P. and Aarons, L. (2000). A pharmacokinetic simulation model for ivabradine in healthy volunteers. European Journal of Pharmaceutical Sciences, 10 (10), 285-294. doi: 10.1016/S0928-0987(00)00086-5
Duffull, S. B. (2000). Drugs and food: Clinically significant interactions. New Ethicals Journal, 3 (2), 43-47.
Conference Papers
Barras, M. A., Duffull, S., Atherton, J. and Green, B. (2007). A Population PKPD Model for Bleeding Events with Enoxaparin. 2007 AAPS Annual Meeting and Exposition, San Diego California, 11th-15th November, 2007.
Roos, J. F., Tett, S. E., Kirkpatrick, C. M. J. and Duffull, S. B. (2007). Development of a sufficient design for parameter estimation of fluconazole population pharmacokinetics in HIV patients. PAGANZ 07: Population Approach Group in Australia & New Zealand, Singapore, 13-15 February 2007. Population Approach Group in Australia and New Zealand.
Hennig, Stefanie and Duffull, Stephen (2007). Different ways of incorporating data below the quantification limit in datasets for parameter estimation. PAGANZ 07: Population Approach Group in Australia and New Zealand, Singapore, 13-15 February 2007. Leiden, Netherlands: Population Approach Group in Europe.
Han, P., Kirkpatrick, C., Duffull, S. and Green, B. (2007). The effect of study design on identifying true covariate relationships. 2007 AAPS Annual Meeting and Exposition, San Diego, CA, U.S.A., 11-15 November 2007.
Tan, S., Duffull, S B and Smith, M T (2006). (PK)PD of the anti-allodynic effects of gabapentin and oxycodone in a neuropathic pain rodent model. PAGANZ 06, Auckland, New Zealand / School of Medicine, 7-9 Feburary, 2006. New Zealand: Population Approach Group in Australia and New Zealand.
Chan, A. S. Y., Duffull, S B, Kirkpatrick, C M J and Isbister, G.K. (2006). Drug-induced QT prolongation and torsades de Pointes: A critical evaluation of the Fossa diagram. The Australian Health & Medical Research Congress, Melbourne Convention Centre, Melbourne, 26 November-1 December 2006. Melbourne: NHMRC.
Hennig, S, Wainwright, C E, Bell, S, Miller, H, Charles, B G and Duffull, S B (2006). A D-optimal designed population pharmacokinetic study of itraconazole. APSA Annual Meeting 2006, Adelaide, Australia, 2-5 December 2006. Adelaide:
Hennig, S., Wainwright, C. E., Bell, S., Miller, H., Charles, B. G. and Duffull, S. B. (2006). A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis. 15th Annual Meeting of the Population Approach Group in Europe, Bruges, Belgium, 14-16 June 2006. PAGE.
McGree, J. M., Duffull, S. B., Eccleston, J. A. and Ward, L. C. (2006). Optimal designs for studying bioimpedance. Royal Statistical Society 2006 Conference, Belfast, 10-14 Sept, 2006.
McGree, J., Duffull, S. B., Eccleston, J. A. and Ward, L. C. (2006). Optimal designs for measuring bioimpedance - design for nonlinear mixed effects models (G5). Designed Experiments: Recent Advances in Methods and Applications, Southampton, 7-10 Sept, 2006.
Kirkpatrick, C M J, Van Den Berg, L and Duffull, S B (2006). TCIWORKS - Target concentration. The Australian Health & Medical Research Congress, Melbourne Convention Centre, Melbourne, 26 November-1 December 2006. Melbourne: NHMRC.
Hennig, S. and Duffull, S B (2006). Different ways of incorporating data below the quantification limit in datasets for parameter estimation. Population Approach Group Australia and New Zealand and the Pn, The University of Queensland / Brisbane, August 2006. Brisbane: PAGJA/PAGANZ.
Hanze, E., Green, B, Duffull, S B, Doogue, M., Begg, E and Kirkpatrick, C M J (2006). The influence of metformin on Hba1c: A PKPD model. 2006 AAPS Annual Meeting and Exposition, Henry B. Gonzalez Convention Center, San Antonio, TX, October 29-November 2, 2006. USA: American Association of Pharmaceutical Scientists.
Janmahasatian, Sarayut, Duffull, Stephen B., Ash, Susan, Ward, Leigh C., Byrne, Nuala M. and Green, Bruce (2005). A semi-mechanistic model for quantification of lean body weight. 14th Conference of the Population Approach Group in Europe, Pamplona, Spain, 16-17 June 2005. Population Approach Group in Europe.
Isbister, G.K., Friberg, L. E., Hackett, L.P. and Duffull, S. B. (2005). Is there value in pharmacokinetic-pharmacodynamic modeling of overdose patients? The example of citalopram and QT prolongation. Joint Meeting of ASCEPT & APSA, Melbourne, Victoria, 4-7 Dec. 2005. Australia: ASCEPT.
Tan, S., Wyse, B. D., Duffull, S. B. and Smith, M. T. (2005). Investigation of temporal changes in the anti-allodynic effectiveness of chronically administered gabapentin in a rat model of neuropathic pain. 11th World Congress on Pain, Sydney, 21-26 August 2005. USA: IASP Press.
Ward, L.C., Duffull, Stephen B. and Elia, M. (2005). Prediction of body composition from BMI: a comparison of equations. 7th International Symposium in Vivo Body Composition Studies, Southampton, United Kingdom, 7-9 Sept, 2005. International Journal of Body Composition Research.
Feng, Y., Green, B., Duffull, S. B., Kane, S. L., Bobek, M. B. and Bies, R. R. (2005). Application of Monte Carlo simulations to identify an appropriate dosage strategy for patients receiving a continuous intravenous infusion of enoxaparin. 2005 Annual Meeting of American Society for Clinical Pharmacology & Therapeutics, Orlando, USA, 2-6 March 2005. St Louis, USA: Mosby. doi: 10.1016/j.clpt.2004.12.230
Friberg, L. E., Dansirikul, C. and Duffull, S. B. (2004). Simultaneous fit of competing models as a model discrimination tool in Bayesian analysis. Population Approach Group in Europe - Thirteenth Meeting (PAGE 2004), Uppsala University, Sweden, 17-18 June 2004. Sweden: Uppsala University.
Friberg, L. E., Isbister, G.K., Dawson, A.H., Hackett, L.P., Whyte, I. M. and Duffull, S. B. (2004). Population pharmacokinetic modelling of citalopram taken in overdose. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing.
Dansirikul, C., Duffull, S. B., Morris, R. and Tett, S.E. (2004). An argument for dose individualisation of sirolimus in renal transplant recipients. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.v31_i11_abs.x
Dansirikul, C., Friberg, L. E., Duffull, S. B., Morris, R. and Tett, S.E. (2004). Bayesian population pharmacokinetic analysis of sirolimus. Population Approach Group in Europe - Thirteenth Meeting (PAGE), Uppsala University, Sweden, 17-18 June 2004. Sweden: Uppsala University.
Kirkpatrick, C. M. J., Duffull, S. B., Barclay, M. L., Patton, N., Moore, G. A. and Doogue, M. P. (2004). Population pharmacokinetic analysis of high-dose oral busulphan for bone marrow transplant in adults and children. 13th Meeting Population Approach Group in Europe (PAGE 2004), Uppsala University, Sweden, 17-18 June, 2004. Sweden: Uppsala University.
Duffull, S. B., Waterhouse, T. H., Redmann, S. and Eccleston, J. A. (2004). A real time optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics. Population Approach Group in Europe - Thirteenth Meeting (PAGE 2004), Uppsala University, Sweden, 17-18 June 2004. Sweden: Uppsala University.
Waterhouse, T. H., Eccleston, J. A. and Duffull, S. B. (2004). On optimal design for discrimination and estimation. Compstat 2004, Prague, Czech Republic, 23-27 August, 2004. Heidelberg: Physica Verlag.
Dansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Limited sampling strategies for monitoring tacrolimus in liver transplant recipients. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney:
Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Detecting drug interactions associated with tacrolimus. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney:
Staatz, C. E., Dansirikul, C., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S. E. (2003). Pharmacodynamic investigations of tacrolimus in liver transplantation. TSANZ 21st Annual Scientific Meeting, Canberra, 9-11 April 2003. Canberra: TSANZ. doi: 10.1046/j.1440-1711.2003.00812.x
Kirkpatrick, C. M. J., Duffull, S. B. and Tett, S. E. (2003). Power calculation for a study with multivariate outcomes. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney:
Dansirikul, C., Choi, M. and Duffull, S. B. (2002). Conversion of non-compartmental to compartmental pharmacokinetics: Proof of concept study. PAGANZ 4th Annual Scientific Meeting, Melbourne, 28-30 Jan. 2002. Melbourne:
Dansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2002). Abbreviated AUC for monitoring tacrolimus in liver transplant recipients. AHMRC 2002, Melbourne, 24-29 Nov. 2002. Melbourne: NHMRC.
Duffull, S. B. (2000). Using computer assisted methods for designing clinical trials. Joint Meeting of ASCEPT and the British Pharmacological Society, Monash University, Melbourne, 3-6 Dec 2000. Melbourne, Vic: Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists.
Duffull, Stephen, Mentré, France and Aarons, Leon (2000). Optimal design of a population pharmacodynamic experiment. Population Approach Group in Europe 2000 - Ninth Meeting, Salamanca, Spain, 15-16 June 2000. Salamanca: Population Approach Group Europe.